Akorn Seeks Del. Ch. 11 OK For $9M Stockholder Suit Deal

By Jeff Montgomery (October 1, 2020, 6:52 PM EDT) -- Bankrupt biopharmaceutical company Akorn Inc. sought a Delaware court's approval late Wednesday for an at least $9 million global settlement of holdout-stockholder suits targeting the company for regulatory and data integrity failures that collapsed its $4.3 billion merger agreement with Fresenius Kabi AG in 2017.

In a motion filed in U.S. Bankruptcy Judge Karen B. Owens' court, Akorn said $9 million was the limit of its available insurance for the cases, creating a cap on total payments available to stockholders who sued. Savings on legal defense fees for directors and officers could be added to the total, however..

The suits the...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!